Health News
Gauging hype during Heart Month: 5 tests you might not need
NEW YORK (Reuters Health) - February is American Heart Month and consumers will be bombarded with advice to keep their ticker healthy -- whether it's from the American Heart Association's Go Red For Women or the National Heart, Lung, and Blood Institute's The Heart Truth.
FDA sets draft rules for biotech drug copies
- The Food and Drug Administration's long-awaited guidelines for the sale of lower-cost versions of biotechnology drugs leave open the possibility that some products might not need to be tested in humans.
New mental health manual is "dangerous" say experts
LONDON - Millions of healthy people - including shy or defiant children, grieving relatives and people with fetishes - may be wrongly labeled mentally ill by a new international diagnostic manual, specialists said on Thursday.
Biden says contraceptives fight can be worked out
WASHINGTON - Vice President Joe Biden said on Thursday the White House was working to address concerns raised by the Catholic Church over a new rule on contraceptives, and he believed an escalating election-year battle over the issue would be resolved.
More evidence big football players face heart risks
- The biggest professional football players in America may be more likely than their fellow players to die of heart disease, even though they appear to generally enjoy a longer-than-average lifespan, according to a U.S. study.
Pentagon attacks obesity with new food choices
LITTLE ROCK, Arkansas - Obese Americans in the military are a national security hazard and U.S. first lady Michelle Obama wants to see that change.
Does sex ed keep girls from becoming teen moms?
NEW YORK (Reuters Health) - In a new study, states with more comprehensive sex education programs had lower teen birth rates -- but the effect seemed to be due more to political, religious and social differences between those states than the sex ed itself.
Most women with cancer want a role in decisions
NEW YORK (Reuters Health) - About two-thirds of women diagnosed with early stage breast cancer want to take part in making decisions about their treatment, according to a new survey of patients from five different countries.
Cancer trial participants may have misconceptions
NEW YORK (Reuters Health) - People enrolled in early stage trials for possible cancer treatments may underestimate the risks involved and overestimate the potential benefits, suggests a new study.
FDA panel rules against NeurogesX patch for HIV
WASHINGTON - A Food and Drug Administration panel of outside experts on Thursday ruled against using a pain-relief product derived from chili peppers to treat the pain that afflicts many HIV patients suffer in their extremities.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
